Stock Price
16.61
Daily Change
-0.92 -5.22%
Monthly
-7.90%
Yearly
-1.57%
Q1 Forecast
16.77

Adma Biologics reported $83.12M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Adma Biologics USD 83.12M 702K Sep/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Dynavax Technologies USD 285.5M 24.99M Jun/2025
Takeda JPY 4.85T 208B Dec/2025